Intervention Review

First-line chemotherapy in low-risk gestational trophoblastic neoplasia

  1. Mo'iad Alazzam1,*,
  2. John Tidy2,
  3. Barry W Hancock3,
  4. Raymond Osborne4,
  5. Theresa A Lawrie5

Editorial Group: Cochrane Gynaecological Cancer Group

Published Online: 11 JUL 2012

Assessed as up-to-date: 30 MAY 2012

DOI: 10.1002/14651858.CD007102.pub3

How to Cite

Alazzam M, Tidy J, Hancock BW, Osborne R, Lawrie TA. First-line chemotherapy in low-risk gestational trophoblastic neoplasia. Cochrane Database of Systematic Reviews 2012, Issue 7. Art. No.: CD007102. DOI: 10.1002/14651858.CD007102.pub3.

Author Information

  1. 1

    The Galway Clinic, Department of Gynaecology, Doughiska, Galway, Ireland

  2. 2

    Sheffield Teaching Hospitals Foundation NHS Trust, Obstetrics & Gynaecology, Sheffield, UK

  3. 3

    Sheffield University, School of Medicine and Biomedical Sciences, Sheffield, UK

  4. 4

    Toronto-Sunnybrook Regional Cancer Centre, Division of Gynecology-Oncology, Toronto, ON, Canada

  5. 5

    Royal United Hospital, Cochrane Gynaecological Cancer Group, Bath, UK

*Mo'iad Alazzam, Department of Gynaecology, The Galway Clinic, Doughiska, Galway, Ireland.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 11 JUL 2012


Cited in:


This article has been cited by:

  1. 1
    F. Taylor, T. Grew, J. Everard, L. Ellis, M.C. Winter, J. Tidy, B.W. Hancock, R.E. Coleman, The outcome of patients with low risk gestational trophoblastic neoplasia treated with single agent intramuscular methotrexate and oral folinic acid, European Journal of Cancer, 2013, 49, 15, 3184